BRIEF published on 06/19/2026 at 15:50, 4 days 12 hours ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Shareholding Technology Platform Atlas Special Opportunities Oxurion
PRESS RELEASE published on 06/19/2026 at 15:45, 4 days 12 hours ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a change in share ownership percentage Transparency Notification Euronext Brussels Share Ownership Oxurion NV Atlas Special Opportunities II LLC
BRIEF published on 06/15/2026 at 19:35, 8 days 8 hours ago Oxurion: Exagis adopted by Pierre Fabre Biopharmaceutical Clinical Data Oxurion Exaggerate Pierre Fabre
BRIEF published on 06/15/2026 at 19:35, 8 days 8 hours ago Oxurion's Exagis Platform Gains Major Market Validation with Pierre Fabre Laboratories Data Management Pharmaceutical Oxurion Pierre Fabre Exagis Platform
PRESS RELEASE published on 06/15/2026 at 19:30, 8 days 8 hours ago Major market validation: Pierre Fabre Laboratories uses Oxurion's Exagis Platform Oxurion NV announces Pierre Fabre Laboratories utilizing Exagis clinical data management platform by Axiodis CRO, enhancing efficiency and compliance. Exagis adapts to various study configurations Oxurion NV Clinical Data Management Axiodis CRO Exagis Pierre Fabre Laboratories
BRIEF published on 06/10/2026 at 18:05, 13 days 10 hours ago Oxurion receives a transparency notification from Atlas Special Opportunities II LLC Shares Transparency Euronext Brussels Oxurion Atlas Special Opportunities II LLC
BRIEF published on 06/10/2026 at 18:05, 13 days 10 hours ago Oxurion Receives Notification on Shareholding Change Shares Transparency Notification Belgium Atlas Special Opportunities Oxurion
PRESS RELEASE published on 06/10/2026 at 18:00, 13 days 10 hours ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding shareholding crossing the threshold. Oxurion is a technology-enabled clinical research company Clinical Research Transparency Notification Shareholding Oxurion NV Atlas Special Opportunities II, LLC
BRIEF published on 06/08/2026 at 21:05, 15 days 7 hours ago Oxurion announces its software strategy with Exagis Growth Strategy Clinical Research Software Oxurion Exaggerate
BRIEF published on 06/08/2026 at 21:05, 15 days 7 hours ago Oxurion Unveils Software-Driven Growth Strategy with Exagis Oxurion Clinical Data Management Exagis Software Strategy EClinical Platform
Published on 06/24/2026 at 03:15, 1 hour 13 minutes ago Noram Lithium Adopts Semi-Annual Financial Reporting
Published on 06/24/2026 at 00:00, 4 hours 28 minutes ago Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Published on 06/23/2026 at 23:45, 4 hours 43 minutes ago Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Published on 06/23/2026 at 23:20, 5 hours 8 minutes ago BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/23/2026 at 23:15, 5 hours 13 minutes ago EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects
Published on 06/24/2026 at 04:00, 28 minutes ago Shipping edges closer to onboard carbon mineralisation as IMO endorses Shanghai Qiyao Technology Group Co., Ltd. proposals
Published on 06/24/2026 at 02:05, 2 hours 23 minutes ago FRONTERA AND KUPARI ANNOUNCE COMMENCEMENT OF STRATEGIC SALE PROCESS FOR THE JOINTLY OWNED PIEDRAS VERDES COPPER MINE COMPLEX IN SONORA, MEXICO
Published on 06/23/2026 at 22:20, 6 hours 8 minutes ago Saudi Properties Portal to Accept Applications for Foreign Real Estate Ownership
Published on 06/23/2026 at 20:15, 8 hours 13 minutes ago EQS-Adhoc: OHB SE resolves on the issue of 1,605,388 new shares representing the first tranche of the up to 8.86% capital increase with subscription rights
Published on 06/23/2026 at 19:47, 8 hours 40 minutes ago GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 9 hours 18 minutes ago GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
Published on 06/23/2026 at 16:47, 11 hours 41 minutes ago Statement of transactions in own shares from June 15, 2026 to June 19, 2026
Published on 06/23/2026 at 15:44, 12 hours 44 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from June 15 to June 19 2026
Published on 06/23/2026 at 14:00, 14 hours 28 minutes ago Neoen awarded long-term contract for new 200 MW / 8-hour battery in Ontario, Canada
